CAPSTONE INVESTMENT ADVISORS, LLC
Position in CRDF — Cardiff Oncology, Inc.
CIK 1426196
NEW YORK, NY
Position in CRDF
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$66,547
-$16,380 QoQ
Shares Held
51,190
0.0% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 104 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPSTONE INVESTMENT ADVISORS, LLC holds $45,989,751 across 38 Biotechnology names. CRDF ranks #37 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
120,000 | $15,927,600 | |
| 2 | TECH |
BIO-TECHNE Corp
|
210,000 | $14,836,500 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
7,200 | $1,348,416 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
222,378 | $816,127 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,240 | $773,189 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,448 | $719,265 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
12,611 | $692,848 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,899 | $571,655 |
All Filings in CRDF
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,547 | 51,190 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $82,927 | 51,190 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $143,843 | 51,190 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $105,451 | 51,190 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $161,248 | 51,190 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $160,736 | 51,190 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $222,164 | 51,190 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $136,677 | 51,190 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $113,641 | 51,190 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $273,354 | 51,190 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $75,761 | 51,190 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $71,154 | 51,190 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $75,249 | 51,190 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $84,463 | 51,190 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $71,666 | 51,190 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $78,832 | 51,190 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $112,618 | 51,190 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $126,951 | 51,190 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $307,651 | 51,190 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $348,644 | 52,349 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $340,413 | 51,190 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $529,857 | 57,220 | Shares | Sole | 2022-02-11 | |
| 2020-12-31 | $2,244,936 | 124,788 | Shares | Sole | 2021-06-21 | |
| No filing history on record for this holder in this stock. | ||||||